Pegvisomant: an advance in clinical efficacy in acromegaly

Keyphrases

• Clinical Efficacy 100%
• Pegvisomant 100%
• Growth Factors 83%
• Insulin-like 83%
• Growth Hormone 50%
• Medical Therapy 33%
• Type 1 Diabetes Mellitus (T1DM) 16%
• Comorbidity 16%
• Hypertension 16%
• Dimerization 16%
• Growth Hormone Receptor 16%
• Subcutaneous Injection 16%
• Age-adjusted 16%
• Disease Control 16%
• Dopamine Agonist 16%
• Premature Mortality 16%
• Pituitary Tumor 16%
• Hormone Activity 16%
• Headache 16%
• Chronic Disorders 16%
• Somatostatin Analogs 16%
• Paresthesia 16%
• New Growth 16%
• Sweating 16%
• Sleep Apnea 16%
• Growth Hormone Receptor Antagonist 16%
• Arthralgia 16%
• Optimal Surgery 16%
• Tachyphylaxis 16%
• Symptomatic Control 16%
• Innovative Therapies 16%
• Target Concentration 16%
• Optimal Current 16%

Medicine and Dentistry

• Acromegaly 100%
• Pegvisomant 100%
• Somatomedin C 83%
• Combination Therapy 33%
• Growth Hormone 33%
• Growth Hormone Receptor 33%
• Diabetes Mellitus 16%
• Comorbidity 16%
• Premature Mortality 16%
• Headache 16%
• Arthralgia 16%
• Paresthesia 16%
• Tachyphylaxis 16%
• Dopamine Agonist 16%
• Somatostatin Derivative 16%
• Experimental Therapy 16%
• Chronic Disorder 16%
• Sweating 16%
• Subcutaneous Injection 16%
• Growth Hormone Secreting Adenoma 16%
• Hormone Receptor Blocking Agent 16%
• Obstructive Sleep Apnea 16%
• Diseases 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Acromegaly 100%
• Pegvisomant 100%
• Somatomedin C 83%
• Combination Therapy 33%
• Growth Hormone 33%
• Growth Hormone Receptor 33%
• Diseases 33%
• Subcutaneous Injection 16%
• Dopamine Receptor Stimulating Agent 16%
• Diabetes Mellitus 16%
• Premature Mortality 16%
• Comorbidity 16%
• Headache 16%
• Somatostatin Derivative 16%
• Hormone Receptor Blocking Agent 16%
• Tachyphylaxis 16%
• Arthralgia 16%
• Paresthesia 16%
• Growth Hormone Secreting Adenoma 16%
• Sleep Disordered Breathing 16%